Fwd: DRUG STUDY SEES UP TO 92-PERCENT CUT IN HIV RISK AMONG GAYS
Drug study sees up to 92-percent cut in HIV risk among gays Article Date: 20 Jul, 2011 Upload Date: 20 Jul, 2011 ROME — Volunteers who responded most to a cocktail of antiretroviral drugs in an HIV prevention trial among gay men had a reduced risk of 92 percent of being infected by the AIDS virus, researchers said on Wednesday. They presented the work as a last-minute, or "late-breaker", contribution to the world forum on AIDS science in Rome . The research looked at a group of men who took part in a major trial called iPrEx HIV Prevention Study. iPrEx explored the idea that an uninfected person taking daily AIDS drugs could be shielded from the human immunodeficiency virus (HIV), a novel approach called pre-exposure prophylaxis, or PrEP. The overall findings, published last November, found that use of a drug called Truvada reduced HIV infections by 44 percent compared with a dummy pill, also called a placebo. The new study looked at a